National Center for Complementary & Alternative Medicine; Notice of Closed Meetings, 9953-9954 [05-3869]

Download as PDF Federal Register / Vol. 70, No. 39 / Tuesday, March 1, 2005 / Notices cough sound index (CSI) can be used in diagnostic applications. Auscultatory Training System Walter McKinney, et al. U.S. Patent Application No. 10/135,964 filed April 29, 2002, Canadian Application No. 2,382,786 filed April 22, 2002 CDC Reference No. I–037–00/0— Research Tool This auscultatory training apparatus includes a database of prerecorded physiological sounds (e.g., lung, bowel, or heart sounds) stored on a computer for playback. A user friendly, graphical interface software program is stored on the computer for use with a conventional computer mouse. The program allows a user to select prerecorded sounds for playback. In addition, the program is operable to generate an inverse model of the playback system in the form of a digital filter. The inverse model processes the selected sound to cancel the distortions of the playback system so that the sound is accurately reproduced. The program also permits the extraction of a specific sound component from a prerecorded sound so that only the extracted sound component is audible during playback. As well as a teaching tool to instruct the user on various body sounds, this invention could have applications as a diagnostic screening tool and as a telemedicine tool. Imaging/Motorized Nail Press: Automated Instrumentation for the Assessment of Peripheral Vascular Function Anne M. Brumfield, et al. U.S. Patent Application No. 60/578,174 filed on June 8, 2004, Australia Patent Application No. 2004203059 filed on July 6, 2004, Canada Patent Application No. 2,474,841 CDC Reference No. I–028–02—Research Tool The nail press test has been used by clinicians to assess peripheral circulatory function. Following a ten second press of the fingernail, a visual determination of the rate of blood flow return is made, as evidenced by the return of color to the fingernail. Far from being standardized, the results of the test are qualitative and subjective. New instrumentation representing an automated version of the nail press has been built which utilizes a computercontrolled linear stepper motor to apply the desired force level. Blood volume and force measurements are acquired before, during and after the press. This VerDate jul<14>2003 14:21 Feb 28, 2005 Jkt 205001 non-invasive and painless test provides physiologically relevant data while standardizing the force application, press duration, and the criteria for determining the precise time of blood flow return. Dated: February 18, 2005. James D. Seligman, Associate Director for Program Services, Centers for Disease Control and Prevention. [FR Doc. 05–3891 Filed 2–28–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES 9953 For Further Information Contact: Roger Rosa, Executive Secretary, BSC, NIOSH, CDC, 200 Independence Avenue, SW., Room 715H, Washington, DC 20201, telephone (202) 205– 7856, fax (202) 260–4464. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 25, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–3889 Filed 2–28–05; 8:45 am] Centers for Disease Control and Prevention BILLING CODE 4163–19–P The Board of Scientific Counselors, National Institute for Occupational Safety and Health (NIOSH) DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: Name: Board of Scientific Counselors (BSC), NIOSH. Time and Date: 9 a.m.–3 p.m., March 23, 2005. Place: Washington Court Hotel on Capital Hill, 525 New Jersey Avenue, NW., Washington, DC 20001, telephone (202) 628– 2100, fax (202) 879–7918. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people. Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors, NIOSH shall provide guidance to the Director, NIOSH on research and preventions programs. Specifically, the Board shall provide guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board shall evaluate the degree to which the activities of the NIOSH: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results. Matters to be Discussed: Agenda items include a report from the Director of NIOSH; proposed revisions to the National Occupational Research Agenda; collaborations with the Occupational Safety and Health Administration; occupational safety and health surveillance; the health hazard evaluation program; and closing remarks. Agenda items are subject to change as priorities dictate. PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; RFA AIDS. Date: March 28, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Jeanette M. Hosseini, Scientific Review Administrator, National Center for Complementary and Alternative Medicine, 6707 Democracy Blvd, Suite 401, Bethesda, MD 20892, (301) 594–9096. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel, Improving Measurement Tools for Sternal Skin Conductance and Hot Flashes SEP. Date: April 22, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\01MRN1.SGM 01MRN1 9954 Federal Register / Vol. 70, No. 39 / Tuesday, March 1, 2005 / Notices Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Laurie Friedman Donze, PhD, Scientific Review Administrator, National Center for Complement & Alt. Medicine, National Institutes of Health, 6707 Democracy Blvd. Suite 401, Bethesda, MD 20892, 301–402–1030, donzel2@mail.nih.gov. Dated: February 18, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–3868 Filed 2–28–05; 8:45 am] Dated: February 18, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–3869 Filed 2–28–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Deafness and Other Communication Disorders; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDCD. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Board of Scientific Counselors, NIDCD. Date: March 25, 2005. Time: 1 p.m. to 2 p.m. Agenda: Reports from Institute Staff. Place: National Institutes of Health, 5 Research Court, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Robert J. Wenthold, PhD, Director, Division of Intramural Research, National Institute on Deafness, and Other Communication Disorders, 5 Research Court, Room 2B28, Rockville, MD 20852, 301–402– 2829. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) VerDate jul<14>2003 14:21 Feb 28, 2005 Jkt 205001 BILLING CODE 4140–01–M National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Services Conflicts 1. Date: March 15, 2005. Time: 3 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Aileen Schulte, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–1225, aschulte@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Diversity Training Programs in Mental Health. Date: March 22, 2005. Time: 3:30 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Bettina D. Acuna, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd, Room 6154, MSC 9609, PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 Bethesda, MD 20892–9609, 301–443–1178, acunab@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clincians, and Research Scientist Award; 93.282, Mental health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: February 22, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–3872 Filed 2–28–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Services Conflicts II. Date: March 14, 2005. Time: 3 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852; (Telephone Conference Call). Contact Person: Aileen Schulte, PhD., Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–1225; aschulte@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Intervention Fellowship Review. Date: March 15, 2005. Time: 11:30 a.m. to 3:30 p.m. E:\FR\FM\01MRN1.SGM 01MRN1

Agencies

[Federal Register Volume 70, Number 39 (Tuesday, March 1, 2005)]
[Notices]
[Pages 9953-9954]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3869]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel; RFA AIDS.
    Date: March 28, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Jeanette M. Hosseini, Scientific Review 
Administrator, National Center for Complementary and Alternative 
Medicine, 6707 Democracy Blvd, Suite 401, Bethesda, MD 20892, (301) 
594-9096.
    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel, Improving Measurement 
Tools for Sternal Skin Conductance and Hot Flashes SEP.
    Date: April 22, 2005.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 9954]]

    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Laurie Friedman Donze, PhD, Scientific Review 
Administrator, National Center for Complement & Alt. Medicine, 
National Institutes of Health, 6707 Democracy Blvd. Suite 401, 
Bethesda, MD 20892, 301-402-1030, donzel2@mail.nih.gov.


    Dated: February 18, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-3869 Filed 2-28-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.